A A A

Current review panels

Review panels are composed for specific competitions and membership will depend on the expertise needed. Please select the appropriate competition for current information on panel composition.

Note:

For competitions with an LOI stage - panels may be reduced between stages depending on expertise required to review the full application. Panel members participating in the LOI review only will be marked with an *.

For competitions with multiple panels – applicants indicate their panel recommendation, however, final panel selection will be determined by the panel chairs and CCSRI based on the panel with the most appropriate expertise.

Innovation Grant and Innovation to Impact Grant panels

I1a - Biomarkers and Genomics

Including genomics, proteomics, metabolomics (and other ‘omics’), high-throughput sequencing, bioinformatics, diagnostic, prognostic and predictive biomarkers, circulating tumour cells.

Panel meeting: June 5, 2014

Wan Lam (Chair) BC Cancer Agency
Vancouver, BC
Kevin Bennewith BC Cancer Research Centre
Vancouver, BC
Paul Boutros Ontario Institute for Cancer Research
Toronto, ON
Robert Day University of Sherbrooke
Sherbrooke, QC
Susan Done Toronto General Hospital/UHN
Toronto, ON
Harriet Feilotter Queen's University
Kingston, ON
Maja Krajinovic CHU Sainte-Justine Research Centre
Montreal, QC
Julian Lum BC Cancer Agency
Vancouver, BC
Arun Seth  University of Toronto
Toronto, ON 
Sohrab Shah BC Cancer Agency
Vancouver, BC
Daniel Sinnett  CHU Sainte-Justine Research Centre
Montreal, QC 
Pierre Thibault  IRIC
Montreal, QC 
William Lockwood
(Scientific Officer)
National Institutes of Health (US)
Bethesda, MD, USA
Sahim Sabri (Scientific Officer)  McGill University
Montreal, QC 
Diane Hawrylenko (Community Representative) Canadian Cancer Society – Ontario Division 
Donna Murrell (Community Representative) Canadian Cancer Society – Ontario Division 

 

I1b - Gene Regulation & Cellular Biology

Including mechanisms of transcriptional control, epigenetics, chromatin structure and function, translational control, RNA biology, post-translational modifications, telomere function, DNA damage and repair, organellar biology, model organisms, angiogenesis, cell migration, cell invasion, tumour environment.

Panel meeting: June 3-4, 2014

John White (Chair) McGill University
Montreal, QC
Shariaz Baksh  University of Alberta
Edmonton, AB 
John J.M. Bergeron  McGill University
Montreal, QC 
Peter Cheung York University
Toronto, ON
Sean Egan  Hospital for Sick Children
Toronto, ON 
Richard Fahlman  University of Alberta
Edmonton, AB 
Gerardo Feybeyre  University of Montreal
Montreal, QC 
Imed Gallouzi  McGill University
Montreal QC 
Anne-Claude Gingras

Mount Sinai Hospital
Toronto, ON

Michael Hallett McGill University
Montreal, QC
Nada Jabado McGill University Health Centre
Montreal, QC
Susan Lees-Miller  University of Calgary
Calgary, AB 
Judy Wong  University of British Columbia
Vancouver, BC 
Karim Mekhail (Scientific Officer) University of Toronto
Toronto, ON 
Christopher Nelson
(Scientific Officer)
University of Victoria
Victoria, BC
Dawn Ashforth (Community Representative) Canadian Cancer Society – Ontario Division 
Brian Marshall (Community Representative) Canadian Cancer Society – Ontario Division

 

I2 - Imaging and Technology Development

Including platform and tool development, systems biology, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, computer tomography (CT), radiobiology, radiotherapy, photodynamic therapy (PDT), optical imaging, microfluidics, nanotechnology.

Panel meeting: June 11, 2014

Lothar Lilge (Chair) Ontario Cancer Institute/PMCC
Toronto, ON
Luc Beaulieu Centre Hospitalier Universitaire de Quebec (CHUQ)
Quebec, QC
Paula Foster Western University
London, ON
Marianne Koritzinsky Ontario Cancer Institute/PMCC
Toronto, ON
Cynthia Ménard  Ontario Cancer Institute/PMCC
Toronto, ON 
Mark Niedre Northeastern University
Boston, MA, USA
Raymond Reilly  University of Toronto
Toronto, ON 
Stefan Reinsberg University of British Columbia
Vancouver, BC
Roger Zemp  University of Alberta
Edmonton, AB 
Sangeeta Murugkar (Scientific Officer) Carleton University
Ottawa, ON 
Aaron Ward
(Scientific Officer)
London Health Sciences Centre
London, ON
Gursharan Gill (Community Representative) Canadian Cancer Society – Ontario Division 
Vanessa Steen (Community Representative) Canadian Cancer Society – Ontario Division 

 

I3 - Immunology, Signalling and Stem Cells

Including metastasis, hormone-sensitive pathways, growth-factor mediated signalling, immunotherapies, viral therapeutics, cancer stem cells, signal transduction, innate immunity and infection, tumour antigens, immune surveillance, hematopoiesis.

Panel meeting: June 11-12, 2014

Tania Watts (Chair) University of Toronto
Toronto, ON
Ninan Abraham  University of British Columbia
Vancouver, BC 
Stephen Girardin  University of Toronto
Toronto, ON 
Mary Hitt  University of Alberta
Edmonton, AB 
Trang Hoang  IRIC
Montreal, QC 
Meredith Irwin 

Hospital for Sick Children
Toronto, ON 

Norman Iscove  Ontario Cancer Institute/PMCC
Toronto, ON 
Kevin Kane University of Alberta
Edmonton, AB
Mani Larijani Memorial University of Newfoundland
St. John's, NL
Catherine O'Brien  Ontario Cancer Institute/PMCC
Toronto, ON 
Arnim Pause  McGill University
Montreal QC 
Sheila Singh McMaster University
Hamilton, ON
Josie Ursini-Siegel McGill University
Montreal, QC
Etienne Gagnon
(Scientific Officer)
University of Montreal
Montreal, QC
Kirstin Hope
(Scientific Officer)
McMaster University
Hamilton, ON
Loradonna Botter (Community Representative) Canadian Cancer Society – Alberta Division 
Lee Jones (Community Representative) Canadian Cancer Society – Ontario Division 

 

I4 - Novel Therapeutics

Including drug candidates, rational drug design, hit and target validation, compound screening, medicinal chemistry, pharmacology, drug delivery systems, drug transport, drug resistance, combination therapies and pharmacogenomics.

Panel meeting: June 9-10, 2014

Craig Thomas (Chair) National Institutes of Health (US)
Rockville, MD, USA
Gervais Bérubé  University of Quebec at Trois-Rivieres
Trois-Rivieres, QC 
Jeremy Duvall  The Broad Institute
Cambridge, MA, USA 
Cheryl Helgason BC Cancer Research Centre
Vancouver, BC
Lisa Marcaurelle  H3 Biomedicine Inc.
Cambridge, MA, USA 
Wilson Miller McGill University
Montreal, QC
Jason Moffat  University of Toronto
Toronto, ON 
Corey Nislow  University of British Columbia
Vancouver, BC           
Linda Penn  Ontario Cancer Institute/PMCC
Toronto, ON 
Kevin Petrecca  McGill University
Montreal, QC 
Lynne-Marie Postovit University of Alberta
Edmonton, AB
Kevin Truong  University of Toronto
Toronto, ON 
David Uehling  Ontario Institute for Cancer Research
Toronto, ON 
Marcel Cypel (Scientific Officer) University of Toronto
Toronto, ON 
Anand Swaminath (Scientific Officer) Juravinski Cancer Centre
Hamilton, ON 
Huda Al-Saedy (Community Representative) Canadian Cancer Society – BC/Yukon Division 
Gillian Cunningham (Community Representative) Canadian Cancer Society – BC/Yukon Division 

 

I5 - Prevention and Cancer Outcomes 

Including epidemiology, prevention interventions, lifestyle and environmental risk factors, health economics, health services, quality of life, survivorship, palliative care, psychosocial issues, knowledge translation and exchange.

Panel meeting: June 3, 2014

Patricia Parker (Chair) University of Texas
Houston, TX, USA
George Astrakianakis University of British Columbia
Vancouver, BC
Kristin Campbell University of British Columbia
Vancouver, BC
Andrea Cherrington University of Alabama at Birmingham
Birmingham, AL, USA
Mary-Jane Esplen Toronto General Hospital
Toronto, ON
Igor Karp University of Montreal
Montreal, QC
Karen Kopciuk  Alberta Health Services
Calgary, AB 
Darren Mays Georgetown University
Washington D.C., USA
Donald McKenzie  University of British Columbia
Vancouver, BC 
Nicole Mittmann  Sunnybrook Research Institute
Toronto, ON 
Paul Villeneuve  Carleton University
Ottawa, ON 
Joanne Kotsopoulos (Scientific Officer) Women’s College Hospital
Toronto, ON 
Lorraine Shack (Scientific Officer) Alberta Health Services
Calgary, AB 
Sharon Chandler (Community Representative) Canadian Cancer Society – Ontario Division 
Charley Hooper (Community Representative) Canadian Cancer Society – Ontario Division 

 

Impact Grant panel

LOI review teleconference: June 23, 2014
Panel meeting: November 19, 2014

John Bell (Co-Chair) Ottawa Hospital Research Institute
Ottawa, ON 
Michael Brundage
(Co-Chair)
Kingston General Hospital
Kingston, ON
Marcel Bally BC Cancer Agency
Vancouver, BC
J. Gregory Cairncross  University of Calgary
Calgary, AB 
Andrew Craig Queen's University
Kingston, ON
Aaron Fenster  Western University
Toronto, ON 
Steven Gallinger  Toronto General Hospital
Toronto, ON 
Cynthia Hawkins 

Hospital for Sick Children
Toronto, ON 

Rayjean Hung  Mount Sinai Hospital
Toronto, ON 
Rama Khokha  Ontario Cancer Institute/PMCC
Toronto, ON 
Nathalie Labrecque University of Montreal
Montreal, QC
David Litchfield  Western University
London, ON 
Calum MacAulay  BC Cancer Agency (Vancouver)
Vancouver, BC 
Ivo Olivotto  Tom Baker Cancer Centre
Calgary, AB 
Claude Perreault  IRIC
Montreal, QC 
Paul Pharoah  University of Cambridge
Cambridge, UK 
Peter Siegel McGill University
Montreal, QC
Gurmit Singh  McMaster University
Hamilton, ON 
Brad Wouters Ontario Cancer Institute/PMCC
Toronto, ON
Jeffrey Wrana Mount Sinai Hospital
Toronto, ON

Prevention Research Grant panel

Panel meeting: June 27, 2014
Alexander S. Parker (Chair)  Mayo Clinic
Jacksonville, FL, USA
Bruce Baskerville University of Waterloo
Waterloo, ON
Jennifer D Brooks  Memorial Sloan-Kettering Cancer Center
New York, NY, USA 
Winson Y. Cheung BC Cancer Agency (Vancouver)
Vancouver, BC
S. Michelle Dreidger

University of Manitoba
Winnipeg, MB

Alison Duncan University of Guelph
Guelph, ON
Heather A. Eliassen

Brigham and Women's Hospital
Boston, MA, USA

Jose R. Fernandez University of Alabama-Birmingham
Birmingham, AL, USA
Vincent Fradet  Laval University
Quebec City, QC 
Walter H. Gotlieb  McGill University
Montreal, QC
Nancy Kreiger Cancer Care Ontario
Toronto, ON
Chizimuzo Okoli  University of Kentucky
Lexington, KT, USA 
Kimberly Robien  George Washington University
Washington, DC, USA 
Alberto Severini  Public Health Agency of Canada
Winnipeg, MB 
Thomas Tenkate  Ryerson University
Toronto, ON 
Enam Alsrayheen (Community Representative) Canadian Cancer Society - British Columbia/Yukon Division 
Sarah Vollett (Community Representative) Canadian Cancer Society - British Columbia/Yukon Division 

CCS-Partner Prevention Research Grant panel

LOI review teleconference: April 29, 2014
Panel meeting: September 30, 2014

Richard (Dick) Clayton (Chair)  University of Kentucky
Lexington, KY, USA
Tracie Barnett  University of Montreal
Montreal, QC 
Ulrike (Uli) Boehmer  Boston University
Boston, MA, USA 
Anne Leis

University of Saskatchewan
Saskatoon, SK

S. Elizabeth McGregor  Alberta Health Services
Calgary, AB 
Marie-Élise Parent 

Institut national de la recherche scientifique
Laval, QC 

Annette Schultz  University of Manitoba
Winnipeg, MB 
Siobhan Sutcliffe  Washington University School of Medicine
St. Louis, MO, USA
Shelley Tworoger  Harvard University
Boston, MA, USA 
Melanie Keats (Scientific Officer) Dalhousie University
Halifax, NS 

Capacity Development Awards in Prevention Research panel

Panel meeting: June 18, 2014

Christine Friedenreich (Chair)  Alberta Health Services – Cancer Care
Calgary, AB
Hal Berman  Toronto General Hospital
Toronto, ON 
Denise Daley University of British Columbia
Vancouver, BC
Geoffrey Fong University of Waterloo
Waterloo, ON 
Katherine Frohlich

University of Montreal
Montreal, QC

Lise Gauvin 

University of Montreal
Montreal, QC 

Sam Harper McGill University
Montreal, QC
Shelley Harris

CancerCare Ontario
Toronto, ON

Julia Knight Mount Sinai Hospital
Toronto, ON
Salaheddin Mahmud University of Manitoba
Winnipeg, MB
Jennifer Yessis (Scientific Officer) 

University of Waterloo
Waterloo, ON 

Quality of Life Grant panel

LOI review teleconference: September 11, 2014
Panel meeting: January 15, 2015

Jamie Studts, PhD 
(Chair)
University of Kentucky
Lexington, KY
Maru Barrera, PhD Hospital for Sick Children
Toronto, ON 
Cristina Caperchione, PhD University of British Columbia (Okanagan)
Kelowna, BC
Anees Chagpar, MD Yale University
New Haven, CT
Catherine Classen, PhD  Women’s College Research Institute
Toronto, ON 
Nicole Culos-Reed, PhD University of Calgary
Calgary, AB 
Kristine Donovan, PhD, MBA  Moffitt Cancer Center and Research Institute
Tampa, FL
Bruno Gagnon, MD Laval University
Quebec City, QC
Melissa Henry, PhD  Jewish General Hospital
Montreal, QC 
Suzanne Lechner, PhD  University of Miami
Miami, FL 
Christopher Longo, PhD McMaster University
Hamilton, ON
Donald Mabbott, PhD Hospital for Sick Children
Toronto, ON
Suzanne O’Neill, PhD Georgetown University
Washington, DC
Gregory Pond, PhD  McMaster University
Hamilton, ON
John Schmidt, PhD  University of Pittsburgh
Pittsburgh, PA 
Allen Sherman, PhD  University of Arkansas for Medical Sciences
Little Rock, AR
Robin Vanderpool, PhD  University of Kentucky
Lexington, KY
Erika Waters, PhD, MPH Washington University in St. Louis
St Louis, MO
Rebecca Wong, MD  Ontario Cancer Institute/PMCC
Toronto, ON 
James Wright, MD  Juravinski Cancer Centre, Hamilton Health Sciences
Hamilton, ON
Sarah Hales, MD (Scientific Officer) Princess Margaret Cancer Centre
Toronto, ON 
Breffni Hannon, MD 
(Scientific Officer)
Princess Margaret Cancer Centre
Toronto, ON

Knowledge to Action Grant panel

Panel meeting: May 13, 2014

Jon Kerner (Chair)  Canadian Partnership Against Cancer
Toronto, ON 
H. Sharon Campbell University of Waterloo
Waterloo, ON
Deborah Dudgeon  Queens University
Kingston, ON 
Melissa Henry McGill University
Montreal, QC 
Deborah K. Mayer  University of North Carolina-Chapel Hill
Chapel Hill, NC 
Marie-Hélène Mayrand  University of Montreal
Montreal, QC 
Martine Puts  University of Toronto
Toronto, ON 
Marko Simunovic McMaster University
Hamilton, ON
Jill Tinmouth  Sunnybrook Research Institute
Toronto, ON 
Jennifer Brunet (Scientific Officer)  University of Ottawa
Ottawa, ON 
Stephen Ng (Community Representative) Canadian Cancer Society - British Columbia/Yukon Division
Vancouver, BC
Ryan Normore (Community Representative)  Canadian Cancer Society - Nova Scotia Division
Bedford, NS

Last modified on: August 15, 2014